tiprankstipranks
Trending News
More News >
Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Intellia Therapeutics (NTLA) Similar Stocks

Compare
4,595 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
$9.44
$1.11B
-2.21
-21.14%
9 Buy
12 Hold
1 Sell
Moderate Buy
Kura Oncology
$11.06
$962.41M
-4.29
22.61%
10 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.14
$914.21M
-11.30
240.13%
7 Buy
0 Hold
0 Sell
Strong Buy
AbCellera Biologics
$3.72
$1.11B
-6.21
19.73%
4 Buy
1 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.31
$860.72M
-73.66%
15 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$17.27
$946.08M
-7.53
-12.13%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NTLA
Intellia Therapeutics
9.44
-2.53
-21.14%
KURA
Kura Oncology
10.63
1.96
22.61%
CMPX
Compass Therapeutics
5.17
3.71
254.11%
ABCL
AbCellera Biologics
3.58
0.59
19.73%
JANX
Janux Therapeutics Inc
14.25
-39.85
-73.66%
BCAX
Bicara Therapeutics Inc.
16.80
-1.47
-8.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts